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1. Introduction 
 
The ability to regulate cell volume is an ancient conserved trait present in essentially all 
species through evolution. The maintenance of a constant cell volume is a homeostatic im-
perative in animal cells. Changes in cell water content affecting the concentration of intra-
cellular messenger molecules impair the complex signaling network, crucial for cell 
functioning and intercellular communication. Although the renal homeostatic mecha-
nisms exert a precise control of extracellular fluid osmolarity, this is challenged in a variety 
of pathological situations. The intracellular volume constancy is continuously compro-
mised by the generation of local and transient osmotic microgradients, associated with nu-
trients uptake, secretion, cytoskeleton remodeling and transynaptic ionic gradients.1 
Cell volume disturbances have particularly dramatic consequences in the brain. The 
limits to expansion imposed by the rigid skull give narrow margins for the buffering of 
intracranial volume changes. As expansion occurs, the constraining of small vessels gen-
erates episodes of anoxia, ischemia, excitotoxicity, and neuronal death. In extreme condi-
tions, caudal herniation of the brain parenchyma through the foramen magnum affects 
brain stem nuclei resulting in death by respiratory and cardiac arrest. 
Brain cell swelling occurs either by decreases in external osmolarity as in hyponatremia 
or by changes in ion redistribution in isosmotic conditions, termed cytotoxic edema. Cells 
exposed to hyposmotic conditions first swell and then exhibit a volume regulatory re-
sponse, accomplished by the extrusion of intracellular osmotic solutes, essentially the in-
organic osmolytes K+ and Cl–, as well as organic osmolytes such as amino acids, poly-
amines, and polyalcohols. This is an active regulatory process (termed regulatory volume 
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decrease, RVD) which occurs in spite of the persistence of the hyposmotic condition. In 
most studies, RVD is investigated by exposure of cells to abrupt and large decreases in 
external osmolarity. Although this condition has been useful to characterize and amplify 
the events occurring during RVD, these drastic changes in external osmolarity occur only 
seldom, even in pathological situations. 
An experimental paradigm developed by Lohr and Grantham2 in renal cells is that of 
exposure of cells to small and gradual changes in osmolarity. Under these conditions, cell 
volume remains constant even after some time of exposure to the osmotic gradient, when 
the external osmolarity has been considerably reduced. This response was named “isovol-
umetric regulation” (IVR). We have characterized this phenomenon in various brain cell 
preparations, including hippocampal slices, cerebellar granule neurons in culture, and C6 
glioma cells. That taurine plays an important role in IVR was demonstrated in all cases. 
 
1.1. Mechanism of Isovolumetric Regulation 
The volume constancy observed in cells exposed to an osmotic gradient may reflect either 
the absence of swelling in these conditions or the activation of mechanisms for volume 
adjustment. The study by Lohr and Grantham supported the last conclusion, since cells 
exposed to gradual decreases in osmolarity, which present IVR, shrink when returned to 
an isosmotic medium, indicative of loss of intracellular osmolytes. IVR in renal cells is 
blocked by ouabain, quinine, and barium, indicating the involvement of K+ as an osmolyte 
in this process.3 Also in A6 cells, a 70% loss of intracellular K+ was found after exposure to 
an osmotic gradient.4 No other potential osmolyte was examined in those studies. 
Subsequently, Souza5 studied IVR in cultured chick embryo cardiomyocytes. In contrast 
to renal cells, in cardiomyocytes only partial IVR was observed, since cells started swelling 
when the external osmolarity had dropped by approximately 15%. At the end of the ex-
periment, a 35% decrease in K+ and a 22% decrease in taurine cell content were observed. 
IVR seems not to be a general feature of all cells. Trout erythrocytes were unable to regulate 
volume in the presence of an osmotic change as low as –0.7 mOsml/min. Neither K+ nor 
taurine fluxes were activated in these cells which explains the absence of the volume reg-
ulatory response.6 
Hippocampal slices7 exposed to an osmotic gradient of –2.5 mOsml/min, are also able 
to maintain a constant volume. In this preparation, no significant change in K+ was found 
during IVR. In contrast, a marked decrease in the concentrations of amino acids of approx-
imately 60% occurred during IVR. The marked reduction of endogenous taurine and glu-
tamate levels of 80% and 65%, respectively, emphasize their contribution to IVR (fig. 1). 
Radiolabeled amino acids were used to examine the time course of taurine, glutamate, and 
GABA release in response to the osmotic gradient. [3H] Taurine release is observed almost 
immediately after the reduction in osmolarity, with a threshold of –5 mOsm, while that of 
glutamate (traced by 3H-aspartate) and [3H] GABA were –20 mOsm. Also the efflux rate of 
taurine is notably higher, with a maximal increase of 7-fold over the isosmotic efflux while 
those of glutamate and GABA were only 2- and 3-fold higher, respectively. Interestingly, 
a similar early release of taurine has been observed in vivo in rat brain in response to hy-
ponatremia.8 All together, these results support the contribution of amino acids to IVR. 
The apparent lack of contribution of K+ to the regulatory process in hippocampal slices is 
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somewhat surprising since this ion is actively participating in IVR in renal cells, A6 cells, 
and cardiomyocytes. It is possible that in an integrated preparation such as the hippocam-
pal slice, an active buffering mechanism of extracellular K+ masks the osmosensitive release 
occurring gradually during IVR. Due to the key role of K+ in the control of neuronal excit-
ability, its extracellular levels have to be strictly controlled. 
 
 
 
Figure 1. Efflux of 3H-taurine and 3H-D-aspartate from hippocampal slices exposed (ar-
row) to medium of decreased osmolarity (●) at a rate of 2.5 mOsm min–1. Controls() were 
superfused with isosmotic medium. Data are expressed as efflux rate constants (min–1) 
and are means ± SEM (n = 8–10). The insets show the decrease of endogenous levels ± SEM 
after expose to isosmotic medium (empty bars) or to the osmotic gradient conditions 
(dashed bars). 
 
Full IVR occurs in cultured cerebellar granule neurons exposed to gradual changes in 
external osmolarity of –1.8 mOsml/min.9 No cell volume increase is observed even when 
the external osmolarity has dropped by 50%. The contribution of K+, Cl– to IVR and of some 
amino acids has been examined in this preparation. As in hippocampal slices, taurine ex-
hibited the earliest efflux threshold, of –2% mosm. Other amino acids are also released in 
response to the osmotic gradient, with thresholds of –19 and –30 mOsm for glutamate and 
glycine, respectively. Cl– (followed as 125I) and K+ (as 86Rb) efflux showed a release thresh-
old of –25 and –29 mOsm, respectively. These results suggest a contribution by amino acids 
in the early phases of IVR, while ions have a contribution only late in the process. 
To evaluate the active contribution of these different osmolytes, suppression of their 
fluxes by several experimental maneuvers was attempted. The rational for these experi-
ments is that a reduction in osmolyte extrusion may result in an increase in cell volume, 
corresponding to the fraction impaired by the blockade of the osmolyte involved. K+ efflux 
is blocked by Ba+2 and in the presence of this agent, cell swelling occurs at external osmo-
larity reduced by 24%, coincident with the 86Rb release threshold (fig. 2B). Similarly cell 
treatment with solutions in which all Cl– was replaced by gluconate, lead to cell swelling 
when the external osmolarity is reduced by –24%, progressively increasing to reach a max-
imum of 29% when the external osmolarity is –50%. Niflumic acid is a blocker of both 
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taurine and Cl– efflux during IVR. In the presence of this compound, swelling is observed 
from the first minutes of exposure to the osmotic gradient, and this increase continues to 
attain a maximal of 50%. This observation indicates that the early phase of volume regula-
tion occurs entirely by a niflumic-acid sensitive mechanism (fig. 2A). Comparing cell swell-
ing in a medium without Cl–, which affects only the Cl– contribution but not that of organic 
osmolytes, and swelling in niflumic acid–containing solutions, gives an estimate of the 
contribution of organic osmolytes. The differences between the two curves suggest an 
early, continuous, and substantial contribution of these types of osmolytes throughout the 
IVR process. The particular features of taurine efflux, being more sensitive and more ro-
bust than that of other amino acids, underline its predominant role in volume regulation 
under IVR conditions. 
 
 
 
Figure 2. Impairment of IVR by niflumic acid, Ba2+, and Cl-free medium. A. Cell volume 
measured in cells exposed to the osmotic gradient (), in the presence of 600 μM niflumic 
acid(●), or Cl–-free medium (Cl– replaced by gluconates) (). In B, cell volume in the pres-
ence of 15 mM Ba+2 (•). Data are means ± SEM of 3–4 separate experiments. 
 
Preliminary studies in C6 cells further support this notion, although mainly by negative 
results. In these cells, the osmotic gradient effectively elicits Cl– and K+ currents, which, 
however, are not sufficient to maintain a constant cell volume. Interestingly, the osmotic 
gradient is unable to evoke taurine efflux. Not even sudden changes in osmolarity of –30% 
evoke any detectable efflux of taurine. Only very large decreases in osmolarity mobilize 
taurine. 
All together, these observations stress the importance of taurine as a volume regulatory 
element in conditions which, as mentioned before, may better fit the physiological and 
pathological situations. 
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